2-pyridinyl-6,7,8,9-tetrahydropyrimido{1,2-a}pyrimidin-4-one and 7-pyridinyl-2,3-dihydoimidazo{1,2-a}pyrimidin-5(1H)one derivatives
US6974819B2 · kind B2 · utility
1Cited by
0References
16Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 31, 2001 |
| Grant date | Dec 13, 2005 |
| Priority date | — |
| Expiry date | Sep 8, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Imidazo[1,2-α]pyrimidinones and pyrimido[1,2-α]pyrimidinones useful for preventive and/or therapeutic treatment of neurodegenerative diseases, such as Alzheimer's disease, caused by abnormal GSK3β activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.